Neuropsychologic, Neuroradiologic, Endocrinologic, & Genetic Aspects of

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the following:

1. Whether Klinefelter Syndrome is associated with altered total and regional brain volumes and altered brain activity.

2. The influence of genetic factors and testosterone treatment on the neuropsychological phenotype, total and regional brain volumes and brain activity in men with Klinefelter syndrome.

Clinical Trial Description

Klinefelter syndrome (KS) is the most common sex-chromosome disorder in men with a prevalence of 1 in 660 men. Men with the syndrome have an additional X-chromosome. The syndrome is associated with cognitive and behavioral dysfunction and also with hypogonadism. Magnetic resonance imaging have pointed to different volumetric alterations in several brain structures. Several genetic factors involving the X-chromosome have been suggested to influence the neuropsychological phenotype in men with KS.

The aim of this study is to investigate the following: 1.Whether KS is associated with altered total and regional brain volumes and altered brain activity. 2.Whether genetic factors influence the neuropsychological phenotype, total and regional brain volumes, and brain activity in men with KS. 3.Whether testosterone treatment improves cognitive skills and change brain activity in men with KS.

Participants are divided in 5 groups: 1. 50 men with KS who receive testosterone treatment. 2. 50 men KS who do not receive testosterone treatment. 3. 100 age-matched control men.4. 50 age-matched control women are included as a control group for X-chromosome inactivation pattern. 5. Parents of KS subjects in group 1 and 2 are included to determine the parental origin of the supernumerary X-chromosome. Methods include a 3-hour battery of standardized neuropsychological tests to cover a broad range of cognitive domains and to assess major domains of personality. We use magnetic resonance imaging to measure total and regional brain volumes and functional magnetic resonance imaging to measure brain activity while subjects are performing a attention-demanding cognitive task. The genetic testing includes the parental origin of the supernumerary X-chromosome, the pattern of X-chromosome inactivation, androgen receptor (AR) CAGn repeat length, and gene expression profile of brain-expressed genes. ;

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00999310
Study type	Observational
Source	University of Aarhus
Contact
Status	Completed
Phase	N/A
Start date	November 2009
Completion date	June 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03396562` - The eXtroardinarY Babies Study: Natural History of Health and Neurodevelopment in Infants and Young Children With Sex Chromosome Trisomy
Completed	`NCT02526628` - Thrombosis and Neurocognition in Klinefelter Syndrome
Completed	`NCT01678261` - X-chromosome Inactivation, Epigenetics and the Transcriptome	N/A
Completed	`NCT01690013` - Life Quality and Health in Patients With Klinefelter Syndrome	N/A
Completed	`NCT01918280` - Fertility Preservation in Cases of Klinefelter Syndrome.	N/A
Completed	`NCT02787486` - Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Completed	`NCT03325647` - TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY	Phase 4
Enrolling by invitation	`NCT03836300` - Parent and Infant Inter(X)Action Intervention (PIXI)	N/A
Recruiting	`NCT05498090` - Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males With Klinefelter Syndrome	Phase 4
Completed	`NCT02408445` - Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment	Phase 4
Completed	`NCT00896272` - Adaptation Among Adolescents and Adults With Klinefelter Syndrome
Completed	`NCT02723305` - Cardiometabolic Profiles of Boys With Klinefelter Syndrome
Completed	`NCT05581147` - Thyroid Function and Structure IN Klinefelter Syndrome
Recruiting	`NCT05586802` - Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome	Phase 3
Active, not recruiting	`NCT02430584` - Whole Blood Specimen Collection From Pregnant Subjects
Completed	`NCT01817296` - Klinefelter Fertility Preservation	N/A
Completed	`NCT01585831` - Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome	N/A
Completed	`NCT01206270` - Androgen for Leydig Cell Proliferation	Phase 2/Phase 3
Withdrawn	`NCT00347464` - Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome	N/A
Recruiting	`NCT05425953` - Endocrine, Metabolic, Cardiovascular and Immunological Aspects of Sex Chromosome Abnormalities in Relation to Genotype

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Neuropsychologic, Neuroradiologic, Endocrinologic, and Genetic Aspects of Klinefelter Syndrome

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms